Guggenheim Capital’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-12,787
Closed -$249K 1930
2023
Q2
$249K Sell
12,787
-3,880
-23% -$75.4K ﹤0.01% 1712
2023
Q1
$473K Buy
16,667
+697
+4% +$19.8K ﹤0.01% 1509
2022
Q4
$467K Buy
15,970
+225
+1% +$6.58K ﹤0.01% 1515
2022
Q3
$416K Sell
15,745
-3,910
-20% -$103K ﹤0.01% 1551
2022
Q2
$873K Buy
19,655
+1,923
+11% +$85.4K 0.01% 1285
2022
Q1
$877K Buy
17,732
+1,402
+9% +$69.3K 0.01% 1424
2021
Q4
$832K Sell
16,330
-7,727
-32% -$394K ﹤0.01% 1451
2021
Q3
$1.34M Buy
24,057
+7,186
+43% +$401K 0.01% 1266
2021
Q2
$722K Buy
+16,871
New +$722K ﹤0.01% 1654
2020
Q3
Sell
-4,319
Closed -$207K 1956
2020
Q2
$207K Sell
4,319
-120,144
-97% -$5.76M ﹤0.01% 1736
2020
Q1
$5.73M Sell
124,463
-703
-0.6% -$32.3K 0.06% 392
2019
Q4
$7.52M Buy
125,166
+3,420
+3% +$205K 0.06% 428
2019
Q3
$6.89M Sell
121,746
-622
-0.5% -$35.2K 0.06% 448
2019
Q2
$6.81M Sell
122,368
-88
-0.1% -$4.9K 0.06% 444
2019
Q1
$6.18M Sell
122,456
-2,187
-2% -$110K 0.05% 504
2018
Q4
$5.02M Buy
124,643
+37,174
+42% +$1.5M 0.04% 563
2018
Q3
$6.06M Sell
87,469
-28,982
-25% -$2.01M 0.04% 614
2018
Q2
$8.81M Sell
116,451
-74,254
-39% -$5.62M 0.06% 381
2018
Q1
$10M Buy
190,705
+54,509
+40% +$2.87M 0.02% 679
2017
Q4
$7.28M Sell
136,196
-5,466
-4% -$292K 0.02% 823
2017
Q3
$8.45M Buy
141,662
+9,489
+7% +$566K 0.02% 753
2017
Q2
$10.4M Buy
132,173
+94,290
+249% +$7.44M 0.03% 656
2017
Q1
$3.14M Sell
37,883
-1,392
-4% -$115K 0.01% 1315
2016
Q4
$3.12M Sell
39,275
-35,814
-48% -$2.84M 0.01% 1323
2016
Q3
$5.26M Buy
75,089
+33,234
+79% +$2.33M 0.02% 990
2016
Q2
$1.62M Buy
41,855
+5,005
+14% +$194K 0.01% 1704
2016
Q1
$1.49M Buy
36,850
+15,804
+75% +$640K ﹤0.01% 1782
2015
Q4
$1.87M Sell
21,046
-889
-4% -$78.8K 0.01% 1665
2015
Q3
$1.62M Buy
+21,935
New +$1.62M 0.01% 1745